| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/2009 | US20090318449 Therapeutic lactams |
| 12/24/2009 | US20090318448 Inhibitors of Bruton's Tyrosine Kinase |
| 12/24/2009 | US20090318447 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia |
| 12/24/2009 | US20090318446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy |
| 12/24/2009 | US20090318445 Pdf inhibitors |
| 12/24/2009 | US20090318444 Tetrahydro- and dihydroquinazolinones |
| 12/24/2009 | US20090318443 Kinase inhibitors |
| 12/24/2009 | US20090318442 Thiazolyl-and oxazolyl-isoquinolinones and methods for using them |
| 12/24/2009 | US20090318441 Pyrrolopyrimidine Compounds and Their Uses |
| 12/24/2009 | US20090318440 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors |
| 12/24/2009 | US20090318439 5-furopyridinone substituted indazoles |
| 12/24/2009 | US20090318438 Heterocyclic compounds and their use as anticancer agents |
| 12/24/2009 | US20090318437 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE |
| 12/24/2009 | US20090318436 Fused heterocyclic derivatives and methods of use |
| 12/24/2009 | US20090318435 Pyrazolopyridines and analogs thereof |
| 12/24/2009 | US20090318434 Composition and process - 356 |
| 12/24/2009 | US20090318433 Very fast time resolved imaging in multiparameter measurement space |
| 12/24/2009 | US20090318432 Nitrate esters of aminoalcohols |
| 12/24/2009 | US20090318431 Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
| 12/24/2009 | US20090318430 Medical use of cyclin dependent kinases inhibitors |
| 12/24/2009 | US20090318429 Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives |
| 12/24/2009 | US20090318428 Heteroaryl derivatives as protein kinase inhibitors |
| 12/24/2009 | US20090318427 Benzodiazepine derivatives for treating hepatitis c infection |
| 12/24/2009 | US20090318426 Use of flumazenil in the manufacture of a medicament for the treatment of depressive disorders |
| 12/24/2009 | US20090318425 Apoptosis signal-regulating kinase 1 inhibitors |
| 12/24/2009 | US20090318424 Novel compounds |
| 12/24/2009 | US20090318423 Ion Channel Modulators & Uses Thereof |
| 12/24/2009 | US20090318422 Ophthalmic percutaneous absorption type preparation |
| 12/24/2009 | US20090318421 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 12/24/2009 | US20090318420 crystal structured 3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride, used for treating angina pectoris, myocardial necrosis, and congestive heart failure; bradycardial agents |
| 12/24/2009 | US20090318419 Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 12/24/2009 | US20090318418 Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 12/24/2009 | US20090318417 a crystal stuctured form of 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]-propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride, useful as bradycardial agents |
| 12/24/2009 | US20090318416 Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 12/24/2009 | US20090318415 Dibenzothiazepine derivatives and uses thereof - 424 |
| 12/24/2009 | US20090318414 Mono and Combination Therapy with M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Prodromal Syndrome |
| 12/24/2009 | US20090318413 Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma |
| 12/24/2009 | US20090318412 Tricyclic heterocyclic compound and use thereof |
| 12/24/2009 | US20090318411 Purine pi3k inhibitor compounds and methods of use |
| 12/24/2009 | US20090318410 Imidazopyridazines as lipid kinase inhibitors |
| 12/24/2009 | US20090318409 Pyrrolidine inhibitors of iap |
| 12/24/2009 | US20090318408 Halo-substituted pyrimidodiazepines |
| 12/24/2009 | US20090318407 Inhibitors of protein kinases |
| 12/24/2009 | US20090318406 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands |
| 12/24/2009 | US20090318405 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 12/24/2009 | US20090318404 Substituted beta-lactams |
| 12/24/2009 | US20090318403 Antibiotic composition |
| 12/24/2009 | US20090318402 Ruthenium (ii) compounds |
| 12/24/2009 | US20090318401 Use of estriol in low doses |
| 12/24/2009 | US20090318400 Method for inhibiting tumor growth with dehydrosulphurenic acid extracted from antrodia cinnamomea |
| 12/24/2009 | US20090318399 Pharmaceutical composition and extract of poria for treating a disease induced from immune disorder |
| 12/24/2009 | US20090318398 Androgen pharmaceutical composition and method for treating depression |
| 12/24/2009 | US20090318397 Combination of Azelastine and Steroids |
| 12/24/2009 | US20090318396 Corticosteroid linked beta-agonist compounds for use in therapy |
| 12/24/2009 | US20090318395 3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases |
| 12/24/2009 | US20090318394 Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
| 12/24/2009 | US20090318392 Biofluid metabolite profiling as a tool for early prediction of autoimmunity and type 1 diabetes risk |
| 12/24/2009 | US20090318391 treatment of mammal with composition comprising an H2-blocker, an anti-inflammatory agent, a cytotoxic agent, optionally, levamisole, a retinoid, an NFkB inhibitor, a redox quinone, an agent that enhances intracellular accumulation of NADH+H+, a poly-alcohol, an inhibitor of pro-angiogenic growth factor |
| 12/24/2009 | US20090318390 Combinations comprising epothilones and pharmaceutical uses thereof |
| 12/24/2009 | US20090318389 Agonists of the sphingosine-1 phosphate receptor |
| 12/24/2009 | US20090318388 Method of activation of oxazaphosphorines |
| 12/24/2009 | US20090318387 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS |
| 12/24/2009 | US20090318385 Pyrazolopyride derivative and phosphodiesterase ( pde) inhibitors containing the same as active ingredient |
| 12/24/2009 | US20090318384 Composition intended for the treatment of amyotrophic lateral sclerosis |
| 12/24/2009 | US20090318383 Compositions and methods for modulation of vascular structure and/or function |
| 12/24/2009 | US20090318381 Halogenated alkyl di-and trisaccharides, pharmaceutical formulations, diagnostic kits and methods of treatment |
| 12/24/2009 | US20090318380 2',4'-substituted nucleosides as antiviral agents |
| 12/24/2009 | US20090318379 Statins for the Treatment of Viral Influenza Infections |
| 12/24/2009 | US20090318378 Antibiotic Combinations For Providing Total Solution to the Treatment of Infections |
| 12/24/2009 | US20090318377 Medicagenic acid saponin and uses thereof |
| 12/24/2009 | US20090318376 High Throughput Screening Method of Binding Inhibitor Between caspase3 and XIAP and Binding Inhibitor Screened Thereby |
| 12/24/2009 | US20090318375 Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same |
| 12/24/2009 | US20090318374 Methods of diagnosing and treating migraine |
| 12/24/2009 | US20090318373 Receptor-type kinase modulators and methods of use |
| 12/24/2009 | US20090318372 Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside |
| 12/24/2009 | US20090318371 Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (microsponged benzoyl peroxide) |
| 12/24/2009 | US20090318370 Novel glycoconjugated chlorin derivatives and method of producing the same |
| 12/24/2009 | US20090318369 Biomarkers for alzheimer's disease and methods using the same |
| 12/24/2009 | US20090318361 Anti-hemorrhage medication pack |
| 12/24/2009 | US20090318359 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 12/24/2009 | US20090318357 Molecules Preferentially Associated with Effector T Cells or Regulatory T Cells and Methods of Their Use |
| 12/24/2009 | US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 12/24/2009 | US20090318348 Proteins, Nucleic Acids Encoding the Same, and Associated Methods of Use |
| 12/24/2009 | US20090318334 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| 12/24/2009 | US20090318332 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/24/2009 | US20090318330 Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take |
| 12/24/2009 | US20090318329 Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors |
| 12/24/2009 | US20090317885 Photoactive Metal Nitrosyls For Blood Pressure Regulation And Cancer Therapy |
| 12/24/2009 | US20090317499 Artemisinins in the clinical and veterinary management of kinetoplastid infections |
| 12/24/2009 | US20090317496 Method for Preventing and Treating the Disease Caused by Vascular Damage and the Use Thereof |
| 12/24/2009 | US20090317493 Trehalose-containing topical drying composition and method of using same |
| 12/24/2009 | US20090317490 Substituted chroman derivatives, medicaments and use in therapy |
| 12/24/2009 | US20090317489 Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof |
| 12/24/2009 | US20090317485 Skin Protectant Spray Compositions |
| 12/24/2009 | US20090317481 Modafinil formulations |
| 12/24/2009 | US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii |
| 12/24/2009 | US20090317479 Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
| 12/24/2009 | US20090317477 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
| 12/24/2009 | US20090317476 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
| 12/24/2009 | US20090317475 Combination antitumor therapies |